These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11586051)

  • 21. Genetic variation and the risk of haloperidol-related parkinsonism in elderly patients: a candidate gene approach.
    Knol W; van Marum RJ; Jansen PA; Strengman E; Al Hadithy AF; Wilffert B; Schobben AF; Ophoff RA; Egberts TC
    J Clin Psychopharmacol; 2013 Jun; 33(3):405-10. PubMed ID: 23609402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic window of serum haloperidol concentration in acute schizophrenia and schizoaffective disorder.
    Ulrich S; Neuhof S; Braun V; Meyer FP
    Pharmacopsychiatry; 1998 Sep; 31(5):163-9. PubMed ID: 9832347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cocaine is a major risk factor for antipsychotic induced akathisia, parkinsonism and dyskinesia.
    Maat A; Fouwels A; de Haan L
    Psychopharmacol Bull; 2008; 41(3):5-10. PubMed ID: 18779773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haloperidol and its tetrahydropyridine derivative (HPTP) are metabolized to potentially neurotoxic pyridinium species in the baboon.
    Avent KM; Usuki E; Eyles DW; Keeve R; Van der Schyf CJ; Castagnoli N; Pond SM
    Life Sci; 1996; 59(17):1473-82. PubMed ID: 8890926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parkinsonism in elderly users of haloperidol: associated with dose, plasma concentration, and duration of use.
    Knol W; van Marum RJ; Jansen PA; Egberts TC; Schobben AF
    J Clin Psychopharmacol; 2012 Oct; 32(5):688-93. PubMed ID: 22926605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: a randomized, double-blind, placebo-controlled study.
    Lohr JB; Liu L; Caligiuri MP; Kash TP; May TA; Murphy JD; Ancoli-Israel S
    Schizophr Res; 2013 Oct; 150(1):289-96. PubMed ID: 23938173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haloperidol and reduced haloperidol serum levels: correlation with psychopathology in acute schizophrenia.
    Stevens A; Mahal A; Gaertner HJ
    Pharmacopsychiatry; 1992 Sep; 25(5):218-23. PubMed ID: 1409866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accidental haloperidol poisoning in children.
    Gajre MP; Jain D; Jadhav A
    Indian J Pharmacol; 2012; 44(6):803-4. PubMed ID: 23248417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse effects of risperidone and haloperidol treatment in schizophrenia.
    Yen YC; Lung FW; Chong MY
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):285-90. PubMed ID: 14751424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
    Avent KM; DeVoss JJ; Gillam EM
    Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1-Methyl-4-phenylpyridinium-like neurotoxicity of a pyridinium metabolite derived from haloperidol: cell culture and neurotransmitter uptake studies.
    Bloomquist J; King E; Wright A; Mytilineou C; Kimura K; Castagnoli K; Castagnoli N
    J Pharmacol Exp Ther; 1994 Aug; 270(2):822-30. PubMed ID: 8071874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report.
    Volavka J; Cooper TB; Meisner M; Bitter I; Czobor P; Jaeger J
    Psychopharmacol Bull; 1990; 26(1):13-7. PubMed ID: 2371368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of haloperidol and reduced haloperidol in human serum by liquid chromatography after fluorescence labeling based on the Suzuki coupling reaction.
    Kishikawa N; Hamachi C; Imamura Y; Ohba Y; Nakashima K; Tagawa Y; Kuroda N
    Anal Bioanal Chem; 2006 Oct; 386(3):719-24. PubMed ID: 16957915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic evaluation of rating scales for drug-induced parkinsonism and recommendations for future research.
    Knol W; Keijsers CJ; Jansen PA; van Marum RJ
    J Clin Psychopharmacol; 2010 Feb; 30(1):57-63. PubMed ID: 20075649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperactive behavioural effects induced by intranigral infusion of a pyridinium metabolite of haloperidol in rats.
    Fang J
    Can J Physiol Pharmacol; 1996 Dec; 74(12):1359-61. PubMed ID: 9047047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
    Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
    Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diurnal variations of extrapyramidal symptoms induced by haloperidol in schizophrenic subjects.
    Torner C; Herrera-Estrella M; Gutiérrez JA; Aguilar-Roblero R
    Int J Neuropsychopharmacol; 2003 Sep; 6(3):243-6. PubMed ID: 12974990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial effects of ondansetron as an adjunct to haloperidol for chronic, treatment-resistant schizophrenia: a double-blind, randomized, placebo-controlled study.
    Zhang ZJ; Kang WH; Li Q; Wang XY; Yao SM; Ma AQ
    Schizophr Res; 2006 Dec; 88(1-3):102-10. PubMed ID: 16959472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haloperidol plasma levels and dose optimization.
    Coryell W; Miller DD; Perry PJ
    Am J Psychiatry; 1998 Jan; 155(1):48-53. PubMed ID: 9433338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.